Pharmaceutical research and development
Statistics report about R&D in the pharmaceutical industry
This report presents key facts and figures about research and development in the pharmaceutical industry worldwide. The pharmaceutical industry is one of the segments most driven by innovation through research and development investments. This report gives you an overview about pharmaceutical R&D in general, the top companies, characteristics of the current R&D pipeline, and many more.
Report Details
Pharmaceutical research and development
Pages
40 Pages
Format
PPTX
,
PDF
Language
English
Released
2026
Access
Download from this page
Comprehensive data insights
Includes all relevant statistics
Compiled by our industry experts
Table of contents
Market overview & investment trends
3
Premium
Statistic
Total global pharmaceutical R&D spending 2016-2030
Premium
Statistic
R&D spending growth worldwide on pharmaceuticals 2019-2032
Premium
Statistic
Growth rate of R&D spending in pharmaceutical industry by major region 2010-2024
R&D ecosystem & company landscape
6
Premium
Statistic
Major 50 pharmaceutical companies - Rx sales and R&D spending 2024
Basic
Statistic
Pharma companies worldwide with active R&D pipelines 2001-2026
Premium
Statistic
Distribution of pharmaceutical R&D companies by region 2025 vs. 2026
Premium
Statistic
R&D spending share of top pharmaceutical companies 2024
Basic
Statistic
Major pharmaceutical companies in R&D spending growth in 2024
Premium
Statistic
Top pharma companies worldwide 2026, by size of R&D pipeline
R&D pipeline size and top assets
4
Premium
Statistic
Number of drugs in the R&D pipeline worldwide 2001-2026
Basic
Statistic
Drugs in R&D pipeline worldwide 2025-2026, by phase of development
Premium
Statistic
Pharmaceutical industry - number of new substances 1998-2025
Basic
Statistic
Projected most valuable R&D projects based on net present value 2026
Characteristics of R&D pipeline
5
Basic
Statistic
Top therapeutic categories worldwide 2026, by number of R&D products
Premium
Statistic
Worldwide top diseases 2026, by number of drugs in R&D
Basic
Statistic
Worldwide major types for pipeline drugs by number of active drugs 2026
Basic
Statistic
Worldwide pipeline drugs by delivery route share 2025 vs. 2026
Basic
Statistic
Worldwide top drug-producing mechanisms of action by number of active compounds 2026
Duration, cost and ROI
7
Basic
Statistic
Average length of a clinical trial cycle 2020-2024
Premium
Statistic
U.S. drug development phase success rates 2011-2020
Premium
Statistic
Clinical trial success rates by therapeutic area 2020
Premium
Statistic
Clinical trial LoA of top pharma companies 2006-2022
Premium
Statistic
Average R&D cost to develop new biopharma compound 2013-2025
Premium
Statistic
Average peak sales forecast per new biopharmaceutical asset 2013-2025
Basic
Statistic
Rate of return on biopharma R&D late-stage pipeline 2013-2025
Outsourced R&D
6
Basic
Statistic
CRO market size worldwide forecast 2032
Premium
Statistic
Leading global contract research organizations 2025, based on revenue
Premium
Statistic
CDMO market size worldwide forecast 2025-2034
Basic
Statistic
Leading pharma contract development and manufacturing companies 2024
Premium
Statistic
Likelihood of outsourcing drug development activities by biopharma companies 2025
Premium
Statistic
Outsourcing in clinical development among global biopharma companies by size 2025
FURTHER REPORTS
Recommended and recent reports
Recommended statistics
You may also be interested in...